Reuters - Johnson & Johnson on Friday said U.S. health regulators would not approve the company's next-generation schizophrenia drug, paliperidone extended-release, until certain conditions are met.

"If you or someone you know shows signs of the NEW FLU...

Massaro: Physician's passion is public service Rocky Mountain News, CO - ... worked for the New York Department of Public Health. After she finished her medical training, she went to work for the Centers for Disease Control in Atlanta. ...